Alzheimer's Disease Clinical Trials in Philadelphia

Showing 41-60 of 127 trials

Study to Assess the Safety and Biological Activity of AMX0035 for the Treatment of Alzheimer's Disease

NCT03533257

The study is a 24-week, randomized, double-blind, multi-site, placebo-controlled study in participants with mild cognitive impairment (MCI) or early dementia due to Alzheimer's disease (AD).

Alzheimer Disease

Amylyx Pharmaceuticals Inc.95 participantsStarted Sep 2018

Jacksonville, Florida, United States • Orlando, Florida, United States • Palmetto Bay, Florida, United States +8 more locations

COMPLETED< 1 mile

TRC-PAD Program: In-Clinic Trial-Ready Cohort

NCT04004767

The purpose of the TRC-PAD study is to develop a large, well-characterized, biomarker-confirmed, trial-ready cohort to facilitate rapid enrollment into AD prevention trials utilizing the APT Webstudy and subsequent referral to in-clinic evaluation and biomarker confirmation. Participants with known biomarker status may have direct referral to the Trial-Ready Cohort. If you are interested in being selected for the TRC-PAD study, you should first enroll in the APT Webstudy (https://www.aptwebstudy.org/welcome).

Preclinical Alzheimer's DiseaseProdromal Alzheimer's DiseaseAlzheimer Disease+1 more

University of Southern California220 participantsStarted Jun 2019

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Sun City, Arizona, United States +42 more locations

Study to Assess the Safety and Biological Activity of AMX0035 for the Treatment of Alzheimer's Disease

TRC-PAD Program: In-Clinic Trial-Ready Cohort

Alzheimer's Disease Trials in Other Cities

Assessing Clinical Outcomes in Alzheimer's Disease Agitation

Open-Label Study of Leuco-methylthioninium Bis(Hydromethanesulfonate) (LMTM) in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)

Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION)

A Study of Semorinemab in Patients With Moderate Alzheimer's Disease

A Study to Evaluate the Pharmacodynamic (PD) Effects of Once Weekly Administration of Gantenerumab in Participants With Early Alzheimer's Disease (AD)

Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

A Study of Comparing Rates of Dementia and Alzheimer's Disease in Participants Initiating Methotrexate Versus Those Initiating Anti-tumor Necrosis Factor (TNF)-Alpha Therapy

Promoting Independence With Compensatory Cognitive Rehabilitation

Shared Decision Making About Medication Use for People With Multiple Health Problems

A 6-Month Study to Evaluate the Safety & Potential Efficacy of Trappsol Cyclo in Patients With Early Alzheimer's Disease

Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)

RCT of Brain Longitudinal Biomarker Study (OPT-Neuro RCT)

The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)

Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment Study

Repurposing Nucleoside Reverse Transcriptase Inhibitors for Treatment of AD

Practice of Acceptance, Awareness, and Compassion in Caregiving (PAACC)

Multiple Ascending Dose Safety, Tolerability, PK Study of AL001 in Alzheimer's Disease Patients & Healthy Adult Subjects

Other Conditions in Philadelphia